Lv1
10 积分 2024-12-10 加入
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
4天前
已完结
Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-Analysis
3个月前
已完结
MPES-R: Multi-Parameter Evidence Synthesis in R for Survival Extrapolation—A Tutorial
3个月前
已完结
皖公网安备34019202002308
